Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Terry C Burns

Showing results (81-90 of 111) with videos related to

Pageof 12
Sort By:
Medrxiv : the Preprint Server for Health Sciences|March 13, 2023
Cerebrospinal fluid 2-hydroxyglutarate (2-HG) as a monitoring biomarker for IDH-mutant gliomasCecile Riviere-Cazaux, Jean M Lacey, Lucas P Carlstrom, et al.
Neuro-Oncology Advances|July 1, 2026
Defining rapid early progression in glioblastoma-A volumetric approachVikram Munlapudi, Jacob Guzzino, David J Crompton, et al.
EMBO Molecular Medicine|February 19, 2025
Targeting cIAP2 in a novel senolytic strategy prevents glioblastoma recurrence after radiotherapyNozomi Tomimatsu, Luis Fernando Macedo Di Cristofaro, Suman Kanji, et al.
Neuro-Oncology|February 28, 2026
DNA copy number patterns reveal prognostic markers and elucidate mechanisms of evolution in IDH-mutant astrocytomaKristen L Drucker, Arijit Panda, Paul A Decker, et al.
Neuro-Oncology|February 13, 2020
Consensus recommendations for a standardized brain tumor imaging protocol for clinical trials in brain metastasesTimothy J Kaufmann, Marion Smits, Jerrold Boxerman, et al.
Neuro-Oncology Advances|July 25, 2025
Dissecting the biology of gliomagenesis: Evaluating the interaction between <i>IDH</i> tumor mutation and germline variantsMatthew L Kosel, Paul A Decker, Thomas M Kollmeyer, et al.
Molecular Cancer Research : MCR|February 22, 2022
Selective Vulnerability of Senescent Glioblastoma Cells to BCL-XL InhibitionMasum Rahman, Ian Olson, Moustafa Mansour, et al.
NPJ Precision Oncology|November 29, 2023
An untapped window of opportunity for glioma: targeting therapy-induced senescence prior to recurrenceCecile Riviere-Cazaux, Lucas P Carlstrom, Bryan J Neth, et al.
Neuro-Oncology Advances|March 30, 2026
Comparison of clinical, radiographic and genomic alterations between histologic and molecular glioblastoma, <i>IDH</i>-wildtypeDaniel H Lachance, Paul A Decker, Thomas M Kollmeyer, et al.
Biorxiv : the Preprint Server for Biology|June 5, 2026
CSF-Seq enables transcriptome-wide profiling of cerebrospinal fluid and identifies prognostic signature of leptomeningeal diseaseMaxine Umeh Garcia, Giuseppe Barisano, Pablo Nunez Perez, et al.
Pageof 12

Showing results (81-90 of 111) with videos related to

Sort By:
Pageof 12
Medrxiv : the Preprint Server for Health Sciences|March 13, 2023
Cerebrospinal fluid 2-hydroxyglutarate (2-HG) as a monitoring biomarker for IDH-mutant gliomasCecile Riviere-Cazaux, Jean M Lacey, Lucas P Carlstrom, et al.
Neuro-Oncology Advances|July 1, 2026
Defining rapid early progression in glioblastoma-A volumetric approachVikram Munlapudi, Jacob Guzzino, David J Crompton, et al.
EMBO Molecular Medicine|February 19, 2025
Targeting cIAP2 in a novel senolytic strategy prevents glioblastoma recurrence after radiotherapyNozomi Tomimatsu, Luis Fernando Macedo Di Cristofaro, Suman Kanji, et al.
Neuro-Oncology|February 28, 2026
DNA copy number patterns reveal prognostic markers and elucidate mechanisms of evolution in IDH-mutant astrocytomaKristen L Drucker, Arijit Panda, Paul A Decker, et al.
Neuro-Oncology|February 13, 2020
Consensus recommendations for a standardized brain tumor imaging protocol for clinical trials in brain metastasesTimothy J Kaufmann, Marion Smits, Jerrold Boxerman, et al.
Neuro-Oncology Advances|July 25, 2025
Dissecting the biology of gliomagenesis: Evaluating the interaction between <i>IDH</i> tumor mutation and germline variantsMatthew L Kosel, Paul A Decker, Thomas M Kollmeyer, et al.
Molecular Cancer Research : MCR|February 22, 2022
Selective Vulnerability of Senescent Glioblastoma Cells to BCL-XL InhibitionMasum Rahman, Ian Olson, Moustafa Mansour, et al.
NPJ Precision Oncology|November 29, 2023
An untapped window of opportunity for glioma: targeting therapy-induced senescence prior to recurrenceCecile Riviere-Cazaux, Lucas P Carlstrom, Bryan J Neth, et al.
Neuro-Oncology Advances|March 30, 2026
Comparison of clinical, radiographic and genomic alterations between histologic and molecular glioblastoma, <i>IDH</i>-wildtypeDaniel H Lachance, Paul A Decker, Thomas M Kollmeyer, et al.
Biorxiv : the Preprint Server for Biology|June 5, 2026
CSF-Seq enables transcriptome-wide profiling of cerebrospinal fluid and identifies prognostic signature of leptomeningeal diseaseMaxine Umeh Garcia, Giuseppe Barisano, Pablo Nunez Perez, et al.
Pageof 12